Oncology & Cancer

Researchers find new drug target for lung cancer

Drugs targeting an enzyme involved in inflammation might offer a new avenue for treating certain lung cancers, according to a new study by scientists at the Salk Institute for Biological Studies.

Oncology & Cancer

Unlocking the genetic and molecular mystery of soft-tissue sarcoma

Scientists at Joslin Diabetes Center in Boston have uncovered important molecular and genetic keys to the development of soft-tissue sarcomas in skeletal muscle, giving researchers and clinicians additional targets to stop ...

Diseases, Conditions, Syndromes

New drug target for kidney disease discovered

Two discoveries at UC Santa Barbara point to potential new drug therapies for patients with kidney disease. The findings are published in this week's issue of the Proceedings of the National Academy of Sciences.

Oncology & Cancer

Novel mechanism supports antitumor response and T-cell survival

A recent Northwestern Medicine study has discovered a previously unknown molecular mechanism that supports antitumor responses and cell survival in cytotoxic immune cells, according to findings published in the Journal of ...

page 7 from 21